Identification of predicted individual treatment effects in randomized clinical trials
暂无分享,去创建一个
Daniel L. Oberski | Dawn K. Wilson | E. Stuart | H. Ishwaran | T. Jaki | D. Feaster | Andrea Lamont | Michael D. Lyons | K. Tharmaratnam | M. V. Van Horn | Andrea E. Lamont | D. Wilson
[1] D. Rubin. Estimating causal effects of treatments in randomized and nonrandomized studies. , 1974 .
[2] L. Radloff. The CES-D Scale , 1977 .
[3] M. Gail,et al. Testing for qualitative interactions between treatment effects and patient subsets. , 1985, Biometrics.
[4] P. Holland. Statistics and Causal Inference , 1985 .
[5] Donald B. Rubin,et al. Formal modes of statistical inference for causal effects , 1990 .
[6] Terence P. Speed,et al. Introductory Remarks on Neyman (1923) , 1990 .
[7] R. Simon,et al. Bayesian subset analysis. , 1991, Biometrics.
[8] Z Lou,et al. Tree-structured prediction for censored survival data and the Cox model. , 1995, Journal of clinical epidemiology.
[9] S. Assmann,et al. Subgroup analysis and other (mis)uses of baseline data in clinical trials , 2000, The Lancet.
[10] David E. Booth,et al. Analysis of Incomplete Multivariate Data , 2000, Technometrics.
[11] H. Iyer,et al. Unit–Treatment Interaction and Its Practical Consequences , 2000, Biometrics.
[12] John Van Hoewyk,et al. A multivariate technique for multiply imputing missing values using a sequence of regression models , 2001 .
[13] T. Peters,et al. Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives. , 2001, Health technology assessment.
[14] H. Iyer,et al. EVALUATING SUBJECT-TREATMENT INTERACTION WHEN COMPARING TWO TREATMENTS , 2001, Journal of biopharmaceutical statistics.
[15] R. Simon,et al. Bayesian subset analysis: application to studying treatment‐by‐gender interactions , 2002, Statistics in medicine.
[16] S. Pocock,et al. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practiceand problems , 2002, Statistics in medicine.
[17] Yi Tsong,et al. ISSUES RELATED TO SUBGROUP ANALYSIS IN CLINICAL TRIALS , 2002, Journal of biopharmaceutical statistics.
[18] Roderick J. A. Little,et al. Statistical Analysis with Missing Data: Little/Statistical Analysis with Missing Data , 2002 .
[19] Nicole A. Lazar,et al. Statistical Analysis With Missing Data , 2003, Technometrics.
[20] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[21] D. Ruppert. The Elements of Statistical Learning: Data Mining, Inference, and Prediction , 2004 .
[22] Russell V. Lenth,et al. Statistical Analysis With Missing Data (2nd ed.) (Book) , 2004 .
[23] Jeffrey M. Albert,et al. Individual treatment effects in randomized trials with binary outcomes , 2004 .
[24] D. Rubin. Causal Inference Using Potential Outcomes , 2005 .
[25] S. Lagakos. The challenge of subgroup analyses--reporting without distorting. , 2006, The New England journal of medicine.
[26] James J Heckman,et al. Understanding Instrumental Variables in Models with Essential Heterogeneity , 2006, The Review of Economics and Statistics.
[27] Julie A. Johnson,et al. Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements , 2006, Clinical pharmacology and therapeutics.
[28] Stephen W Lagakos,et al. Statistics in medicine--reporting of subgroup analyses in clinical trials. , 2007, The New England journal of medicine.
[29] Paul R Rosenbaum,et al. Confidence Intervals for Uncommon but Dramatic Responses to Treatment , 2007, Biometrics.
[30] Xiaogang Su,et al. Interaction Trees with Censored Survival Data , 2008, The international journal of biostatistics.
[31] K. Hornik,et al. Model-Based Recursive Partitioning , 2008 .
[32] Hansheng Wang,et al. Subgroup Analysis via Recursive Partitioning , 2009, J. Mach. Learn. Res..
[33] Robert Tibshirani,et al. The Elements of Statistical Learning: Data Mining, Inference, and Prediction, 2nd Edition , 2001, Springer Series in Statistics.
[34] M. LeBlanc,et al. Boosting predictions of treatment success , 2010, Proceedings of the National Academy of Sciences.
[35] Claudio Conversano,et al. Combining an Additive and Tree-Based Regression Model Simultaneously: STIMA , 2010 .
[36] Lei Chen,et al. The mean does not mean as much anymore: finding sub-groups for tailored therapeutics , 2010, Clinical trials.
[37] V. Preedy,et al. Center for Epidemiologic Studies-Depression Scale , 2010 .
[38] Wesley O. Johnson,et al. Interaction trees: exploring the differential effects of an intervention programme for breast cancer survivors , 2011 .
[39] Building Strong Families (BSF) Project Data Collection, 2005-2008, United States , 2011 .
[40] Sebastian Vollmer,et al. Testing for heterogeneous treatment effects in experimental data: false discovery risks and correction procedures , 2014 .
[41] K. Imai,et al. Estimation of Heterogeneous Treatment Effects from Randomized Experiments, with Application to the Optimal Planning of the Get-Out-the-Vote Campaign , 2011, Political Analysis.
[42] L. Tian,et al. Analysis of randomized comparative clinical trial data for personalized treatment selections. , 2011, Biostatistics.
[43] I. Lipkovich,et al. Subgroup identification based on differential effect search—A recursive partitioning method for establishing response to treatment in patient subpopulations , 2011, Statistics in medicine.
[44] A. Gelman,et al. Multiple Imputation with Diagnostics (mi) in R: Opening Windows into the Black Box , 2011 .
[45] J. M. Taylor,et al. Subgroup identification from randomized clinical trial data , 2011, Statistics in medicine.
[46] Xiaogang Su,et al. Tree-structured analysis of treatment effects with large observational data , 2012 .
[47] James Y Dai,et al. Two-stage testing procedures with independent filtering for genome-wide gene-environment interaction. , 2012, Biometrika.
[49] Holly Janes,et al. Assessing Treatment‐Selection Markers using a Potential Outcomes Framework , 2012, Biometrics.
[50] Xin Yan,et al. Facilitating score and causal inference trees for large observational studies , 2012, J. Mach. Learn. Res..
[51] D. Green,et al. Modeling Heterogeneous Treatment Effects in Survey Experiments with Bayesian Additive Regression Trees , 2012 .
[52] Boris Freidlin,et al. Randomized phase II trial designs with biomarkers. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[53] D. Allison,et al. Treatment Heterogeneity and Individual Qualitative Interaction , 2012, The American statistician.
[54] N. Simon,et al. Adaptive enrichment designs for clinical trials. , 2013, Biostatistics.
[55] V. Mor,et al. Different analyses estimate different parameters of the effect of erythropoietin stimulating agents on survival in end stage renal disease: a comparison of payment policy analysis, instrumental variables, and multiple imputation of potential outcomes. , 2013, Journal of clinical epidemiology.
[56] Zhiwei Zhang,et al. Assessing the heterogeneity of treatment effects via potential outcomes of individual patients. , 2013, Journal of the Royal Statistical Society. Series C, Applied statistics.
[57] Wendy J. Mack,et al. Statistical Learning for Biomedical Data , 2013 .
[58] Alex M. Andrew,et al. Boosting: Foundations and Algorithms , 2012 .
[59] C. Shen,et al. Treatment Benefit and Treatment Harm Rate to Characterize Heterogeneity in Treatment Effect , 2013, Biometrics.
[60] Marc Ratkovic,et al. Estimating treatment effect heterogeneity in randomized program evaluation , 2013, 1305.5682.
[61] C. Perou,et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[62] Ilya Lipkovich,et al. Strategies for Identifying Predictive Biomarkers and Subgroups with Enhanced Treatment Effect in Clinical Trials Using SIDES , 2014, Journal of biopharmaceutical statistics.
[63] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[64] Iven Van Mechelen,et al. A comparison of five recursive partitioning methods to find person subgroups involved in meaningful treatment–subgroup interactions , 2013, Advances in Data Analysis and Classification.
[65] David Meyre,et al. Jumping on the Train of Personalized Medicine: A Primer for Non- Geneticist Clinicians: Part 3. Clinical Applications in the Personalized Medicine Area , 2014, Current psychiatry reviews.
[66] Estimating Person-Centered Treatment (Pet) Effects Using Instrumental Variables , 2012, Journal of applied econometrics.
[67] Thomas A. Loughran,et al. On the Importance of Treatment Effect Heterogeneity in Experimentally-Evaluated Criminal Justice Interventions , 2015 .
[68] Lena Osterhagen,et al. Multiple Imputation For Nonresponse In Surveys , 2016 .
[69] Bo Zhang,et al. Use of auxiliary covariates in estimating a biomarker-adjusted treatment effect model with clinical trial data , 2016, Statistical methods in medical research.
[70] Jonah B. Gelbach,et al. Can Variation in Subgroups' Average Treatment Effects Explain Treatment Effect Heterogeneity? Evidence from a Social Experiment , 2014, Review of Economics and Statistics.